We are pleased to announce the successful completion of a £500,000 fundraising, demonstrating strong investor confidence in our vision and capabilities. These funds will accelerate progress across our subsidiaries, driving advancements in lab-grown leather, cultivated meat, regenerative medicine through our corneal technology, and the launch of CytoBoost™—a next-generation cell culture additive addressing diverse markets. This strategic investment strengthens our ability to achieve key milestones and deliver innovative biotechnological solutions that meet growing market demand, while supporting a more sustainable future.
Read the full announcement here:
